More individuals worldwide are acquiring cardiovascular problems, increasing the demand for cardiovascular equipment. Because people are less active, eating badly, and becoming older, cardiac problems are rising.
As medical technology advances, market patterns change. Cardiovascular instruments are adapting to contemporary surgery. Sharper needle tips, better materials, and better manufacturing methods enhance cardiovascular therapy.
The global trend of increased cardiac operations and therapies is obvious. More individuals realize early intervention is crucial, and contemporary medical facilities are simpler to reach. These conditions increase cardiac therapies and cardiovascular needle use.
The market for artery needles is affected by less invasive therapies. As patients and healthcare staff choose less intrusive approaches, specialized technologies are needed to provide precise and effective treatments with less damage.
The cardiovascular needle market is expanding because to global aging. Older folks require more cardiovascular therapies and injections since they have greater cardiovascular diseases. Demographic changes should keep the industry rising in the next years.
Market trends demonstrate that cardiovascular therapy safety and satisfaction are becoming increasingly important. Needle producers are investing in research and development to create needles that pain less, damage tissues less, and improve patient experiences. This accords with the increased emphasis on patient-centered treatment.
Emerging economies are having more cardiac surgeries due to greater healthcare infrastructure, more money to spend, and more heart health awareness. Specialized cardiovascular instruments are in demand as more individuals seek cardiac treatments.
Industry insiders want strategic partnerships to increase their market share. These acquisitions aim to bring together technical experts, increase product availability, and meet cardiac physicians' and hospitals' shifting demands.
High quality standards and strict regulation are transforming the market. Cardiovascular needle manufacturers follow worldwide quality and legislative requirements to ensure safety and efficacy. End-user confidence increases.
Despite their growing importance, heart catheters are costly and hard to procure due to hospital financial constraints. Manufacturers must find cost-effective, high-quality solutions. Manufacturing processes and materials are continually improved to overcome economic issues.
The cardiovascular needle market size is expected to reach USD 146.9 million by 2030 at 6.2% CAGR during the forecast period 2022-2030. Cardiovascular needles are used as a part of various heart and vascular mediations to close the surgical wound. Various surgeries such as cardiovascular surgeries, open heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. Rising number of a patient having cardiovascular disease, diabetes, obesity and increasing aging population is driving the market.
However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.
Cardiovascular Needle Market Segmentations
The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.
On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles. Â
On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others. Â
On the basis of the usage, it is segmented into single use and multiple uses.
On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Cardiovascular Needle Market Regional Analysis
The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.
Europe holds the second position in the global market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.
The Asia Pacific is the fastest growing market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.
On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.
Cardiovascular Needle Market Key Players
Some of the key the players in the cardiovascular needles market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)